Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.21 -0.03 (-0.93%)
As of: Nov 12, 2026 · 9:30 AM EST

Whitehawk Therapeutics (WHWK) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Whitehawk Therapeutics (WHWK) recorded Return on Capital Employed [ROCE] of -57.55% in Q2 2026, down 6.04 percentage points from -51.51% a year earlier but up 38.33 percentage points from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Whitehawk Therapeutics reported Return on Capital Employed [ROCE] of -119.10%, down 39.07 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three straight years, though with a four-year change of +33.06 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -80.02% in FY2024 (-25.50 pp), -54.52% in FY2023 (-13.35 pp), -41.17% in FY2022 (+110.98 pp) and -152.16% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has ranged from -110.71% in Q4 2024 to -36.80% in Q4 2022 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -2.53 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 65.01 percentage points in Q2 2023, against a drop of 329.98 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -95.88% (Q1 2026), -79.22% (Q4 2025) and -66.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Whitehawk Therapeutics 289.11 Mn 119.41 Mn - -51.59%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -51.59%
Jun 30, 2026 -57.55%
Mar 31, 2026 -95.88%
Dec 31, 2025 -79.22%
Sep 30, 2025 -66.11%
Jun 30, 2025 -51.51%
Mar 31, 2025 -45.15%
Dec 31, 2024 -110.71%
Sep 30, 2024 -85.07%
Jun 30, 2024 -83.92%
Mar 31, 2024 -73.25%
Dec 31, 2023 -65.60%
Sep 30, 2023 -55.79%
Jun 30, 2023 -45.20%
Mar 31, 2023 -41.14%
Dec 31, 2022 -36.80%
Sep 30, 2022 -44.02%
Jun 30, 2022 -110.21%
Mar 31, 2022 -87.26%
Dec 31, 2021 -75.11%
API Access

Whitehawk Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=WHWK&period=max&api_key=YOUR_API_KEY